SMA – THERAPY P.261 Long-term follow-up of onasemnogene abeparvovec gene therapy in spinal muscular atrophy type 1 (SMA1)J. Mendell,R. Shell,K. Lehman, M. McColly,L. Lowes,L. Alfano, N. Miller, M. Iammarino,K. Church, F. Ogrinc,H. Ouyang, E. Kernbauer, S. Joshi, D. Sproule, M. Meriggioli, D. Feltner,S. Al-ZaidyNeuromuscular Disorders（2020）引用 2|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
